Communiqués Mymetics Corporation

Actions

MYMX

US62856A3005

Recherche biotechnologique et médicale

Temps Différé OTC Markets Autres places de cotation 18:02:13 11/05/2026			Varia. 5j.	Varia. 1 janv.
0,000300 ^USD	-.--%		-.--%	-

20/11/23	Mymetics Corporation annonce ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023	CI
18/08/23	Mymetics Corporation annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2023	CI

Communiqués

11/04/23	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
27/02/23	MYMETICS CORP : Other Events (form 8-K)	AQ
08/02/23	MYMETICS CORP : Other Events (form 8-K)	AQ
17/01/23	MYMETICS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
28/12/22	MYMETICS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
14/11/22	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
11/08/22	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
13/05/22	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
04/04/22	MYMETICS CORP - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
31/03/22	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
12/11/21	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
16/08/21	MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
17/06/21	MYMETICS CORP : Changes in Registrant's Certifying Accountant (form 8-K)	AQ
31/03/21	MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
23/03/21	Mymetics : Amendment to Quarterly Report (SEC Filing - 10-Q/A)	PU
23/03/21	Mymetics : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
18/11/20	Mymetics : to advance Preclinical Studies for Virosome-based Covid-19 Vaccine through Innosuisse grant	PU
13/11/20	Mymetics : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
02/11/20	Mymetics : Starts Second Preclinical Study for Virosome-based Covid-19 vaccine	PU
15/05/20	MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
30/03/20	MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
07/01/20	MYMETICS CORP : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
11/04/16	Mymetics' : HIV Vaccine Candidate Confirms Promise in Preclinical Study With the Texas Biomedical Research Institute	MW
11/04/16	Mymetics' : HIV Vaccine Candidate Confirms Promise in Preclinical Study With the Texas Biomedical Research Institute	MW
05/04/16	Mymetics : Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate	MW